4Gao Y,Zhao MH,Guo XH,et al.The prevalence and target antigens of anti-thyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism.Endocr.Res,2004,30:205-213. 被引量：1
5Slot MC,Links TP,Stegeman CA,et al.Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with anti-thyroid drugs:A long-term follow-up study.Arthritis Rheum,2005,53:108-113. 被引量：1
6Choi HK,Merkel PA,Walker AM,Niles JL.Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis:prevalence among patients with high titers of antimyeloperoxidase antibodies.Arthritis Rheum,2000,43:405 -413. 被引量：1
7Fujieda M,Hattori M,Kurayama H,et al.Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibodypositive glomerulonephritis associated with propylthiouracil treatment.J Am Soc Nephrol,2002,13:437 -445. 被引量：1
9Yu F,Chen M,Gao Y,et al.Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis.Am J Kidney Dis,2007,49:607-614. 被引量：1
10Noh JY,Asari T,Hamada N,et al.Frequency of appearance of myeloperoxidase-antineutrophil cytop lasmic antibody (MPO-ANCA)in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.Clin Endocrinol (Oxf),2001,54:651-654. 被引量：1
